TYSABRI® NICE APPRAISAL, July 3rd 2007
Tysabri® gains NICE approval for use in highly active relapsing remitting multiple sclerosis following a review and analysis of the evidence prepared by HERON Evidence Development Ltd
Tysabri® gains NICE approval for use in highly active relapsing remitting multiple sclerosis following a review and analysis of the evidence prepared by HERON Evidence Development Ltd